Recent Rash Of Misconduct Cases Puts Self-Monitoring Under Scrutiny

WASHINGTON—Last month, the Public Health Service issued regulations on how federal grantees should respond to allegations of scientific misconduct. The new rules, which take effect November 8, require universities and other institutions to certify that they will follow specific procedures and meet certain timetables in investigating and reporting allegations of misconduct involving their employees. By putting the burden on the institution, the government is abiding by the wishes of t

Written byJeffrey Mervis
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

WASHINGTON—Last month, the Public Health Service issued regulations on how federal grantees should respond to allegations of scientific misconduct. The new rules, which take effect November 8, require universities and other institutions to certify that they will follow specific procedures and meet certain timetables in investigating and reporting allegations of misconduct involving their employees.

By putting the burden on the institution, the government is abiding by the wishes of the scientific community to be given the chance to police itself. Agencies such as the National Institutes of Health are given a major—albeit supporting—role in overseeing their conduct. But several recent cases have cast doubt on whether such a two-step approach is adequate to safeguard public health and ensure that scientists don’t break the law. Among those cases is an unpublicized investigation by NIH into allegations that federal scientists received excessive fees for presenting testimony on a controversial public health issue.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies